← Open Payments lookup

NAVNEET KAUR: Open Payments

NPI 1184317794 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$216 in 10 payments from 8 companies in 2025. Trend: 2023 $328 · 2024 $925 · 2025 $216

Food & beverage: $216
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation2$59
ABBVIE INC.2$49
Astellas Pharma US Inc1$23
Celgene Corporation1$21
AstraZeneca Pharmaceuticals LP1$20
Lilly USA, LLC1$16
Daiichi Sankyo Inc.1$15
Merck Sharp & Dohme LLC1$14

Products named: Fabhalta, SCEMBLIX, IMBRUVICA, Vyloy, EPKINLY, REBLOZYL, ENHERTU, VERZENIO.

Industry payments across CA — which companies pay providers there.